CClinicalTrials.gg
CompletedNCT03712215Updated Aug 13, 2020

STUDY OF ELECTRICAL STIMULATION IN PULMONARY FUNCTION IN INTENSIVE CARE UNIT

An interventional study of Rehabilitation in Respiratory Distress Syndrome, Adult, sponsored by Universidade Metodista de Piracicaba. Completed at 1 site in Brazil. Open to participants aged 60 Years to 80 Years. Per ClinicalTrials.gov, last updated 2020-08-13.

Sponsored by Universidade Metodista de Piracicaba · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
60 Years to 80 Years
Sex
All
01

Study summary

Introduction: The Mechanical Ventilation (MV), a support method used in Intensive Care Units (ICU), reaches approximately 90% of critical patients whose withdrawal process represents 40% of the total time of their use. For this purpose Transcutaneous electrical diaphragmatic stimulation (TEDS), which by means of electrodes placed in motor action points on the phrenic nerve tend to provide improvement of the diaphragm muscle function. Objective: To analyze the effect of two protocols of transcutaneous electrical diaphragmatic stimulation on the ventilatory and cardiorespiratory parameters of critically ill patients. Method: Clinical, longitudinal, prospective, quantitative, single center trial will be performed with 30 (thirty) participants in invasive mechanical ventilatory support, randomly divided into three groups: Experimental Group 1 (GE-1; n = 10) where they will be submitted to the TEDS protocol; Experimental Group 2 (GE-2; n = 10), where they will be submitted to the TEDS protocol based on the studies of Cancelliero et al. (2012); Control Group (GC; n = 10) where they will not be submitted to TEDS. All groups will receive physiotherapeutic care from the staff of the adult ICU of the FHCGV. The interventions will consist of ten sessions of Physical Therapy in each participant in the afternoon shift, for ten consecutive days, 1 time a day. For the TEDS procedure, the Orion TENS II (Orion-SP-Brazil) model will be used, the Wright analogue respirometer (Spire-SP-Brazil) will be used for the minute volume evaluation (V'). The variables of systolic blood pressure (SBP), diastolic blood pressure (DBP), heart rate (HR) and peripheral oxygen saturation (SpO2) will also be monitored in order to verify if the TEDS application interferes with the hemodynamic variables of these patients. The data collected will be linked to Microsoft Office Excel® 2010 software and later transformed into tables and graphs. The information collected will be submitted to statistical analysis through the statistical package SPSS 22.0, applying the descriptive statistics for the characterization of the sample and then selecting the specific tests for the respective variances, adopting a level of significance of p≤0.05 for statistical inferences.

02

Conditions studied

  • Respiratory Distress Syndrome, Adult

Keywords

  • Mechanical Ventilation
  • Electrical Stimulation
  • Diaphragm
  • Ventilometry
  • Physiotherapy
03

In context

Respiratory Distress Syndrome

1,597 studies on the registry are indexed under Respiratory Distress Syndrome; 312 are open to participants now.

This study's enrollment of 30 is below the median of 60 across 961 interventional studies indexed under Respiratory Distress Syndrome.

Browse Respiratory Distress Syndrome studies →

Lead sponsor

Universidade Metodista de Piracicaba is the lead sponsor of 34 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
60 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Individuals of both sexes aged 60 years and older up to 80 years,
  • in invasive MV for more than 48 hours,
  • with respiratory drive,
  • using MV in the mode of intermittent mandatory synchronized ventilation (VMIS) or (VPS),
  • connected to the orotracheal tube or via tracheostomy,
  • hemodynamically stable,
  • neuromuscular junction of the entire diaphragm,
  • absence of sedatives.

Exclusion criteria

Exclusion Criteria:

  • presence of pacemaker, hyperthermia (temperature> 38 ° C),
  • use of neuromuscular blockers,
  • use of thoracic drains, generalized edema,
  • cutaneous lesion in the area of intervention with TEDS.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
30 participants (actual)

Study arms

  • Experimental
    Experimental Group 1

    synchronized FES mode, according to the parameters based on the Gueddes et al., (1991): current frequency (F) 30 Hz; pulse width (T) 0,4 ms; upload time (Rise) 1s; time of muscle contraction (On time) 1 s; down time (Decay) 2s e muscle relaxation time (Off time) 1 s.

    Other: Rehabilitation

  • Experimental
    Experimental Group 2

    the same apparatus will be used, differing in the parameters that will be based on the studies of Cancelliero et al., (2012) for the EDET procedure, being used in synchronized FES mode, with frequency of 30 Hz; pulse width (T) 0,4 ms, climb (ramp) of 0,7 s (maximum value). The support was of 0.4 s, already standardized and fixed in the apparatus

    Other: Rehabilitation

  • No intervention
    Control Group

    The control group (CG) with the same characteristics of the experimental groups will perform conventional physiotherapy

Interventions

  • OtherRehabilitation

    diaphragmatic electrical stimulation

06

What researchers measure

Primary outcomes

  1. Minute volume

    For the evaluation of the minute volume will be used Wright analog breathing apparatus. This analysis will occur during the initial evaluation and at the end of each service. For measurement, the ventilometer will be connected to a filter of the brand HMEF UNDIS MEDICAL for adults with extensible trachea of 15 cm, and it is attached directly to the tracheostomy cannula. The patient will remain for a maximum of one minute outside the MV, obstructing the nose with nose clip to thus measure the minute volume spontaneously.

    Time frame: From date of randomization until the date of first documented progression, assessed up to 24 months

07

Study locations

1 site
  • Hospital de Clínicas Gaspar Viana
    Belém, Pará 66087-660, Brazil
08

References and documents

Publications

  • Yabek SM, Jarmakani JM. Sinus node dysfunction in children, adolescents, and young adults. Pediatrics. 1978 Apr;61(4):593-8. PubMed 662485 ↗
  • Wachtel SS, Basrur P, Koo GC. Recessive male-determining genes. Cell. 1978 Sep;15(1):279-81. doi: 10.1016/0092-8674(78)90103-4. PubMed 699047 ↗
  • Geddes LA, Voorhees WD, Bourland JD, Riscili CE. Optimum stimulus frequency for contracting the inspiratory muscles with chest-surface electrodes to produce artificial respiration. Ann Biomed Eng. 1990;18(1):103-8. doi: 10.1007/BF02368420. PubMed 2306029 ↗
  • Krymskii LD, Nestaiko GV. [Scanning electron microscopy of vessels in normal and pathologic states]. Vestn Akad Med Nauk SSSR. 1975;(11):71-6. No abstract available. Russian. PubMed 775835 ↗
  • Arguelles JE, Franatovic Y, Romo-Salas F, Aldrete JA. Intrabiliary pressure changes produced by narcotic drugs and inhalation anesthetics in guinea pigs. Anesth Analg. 1979 Mar-Apr;58(2):120-3. PubMed 35040 ↗

Individual participant data

Plan to share: Undecided

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 13, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03712215
Lead sponsor
Universidade Metodista de Piracicaba
Collaborators
Universidade do Estado do Pará
Responsible party
Rodrigo Santiago Barbosa Rocha, Phd (Principal invastigator, Universidade Metodista de Piracicaba) — Principal investigator
First posted
Oct 19, 2018
Start date
Sep 4, 2018
Primary completion
Jan 31, 2019
Completion
Jan 31, 2019
Last update
Aug 13, 2020

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion